Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRNX Crinetics Pharmaceuticals Inc.

盘前交易 08-21 04:44:48 EDT

84.69

+0.00

0.00%

盘前84.69

+0.000.00%

04:00 EDT

最高84.74	最低84.67	成交量900.39万
今开84.71	昨收84.69	日振幅0.08%
总市值89.85亿	流通市值80.90亿	总股本1.06亿
成交额7.63亿	换手率9.43%	流通股本9,553万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":84.69,"timestamp":1787256000000,"preClose":84.69,"halted":0,"volume":9003934,"hourTrading":{"tag":"盘前","latestPrice":84.69,"preClose":84.69,"latestTime":"04:00 EDT","volume":1,"amount":84.69,"timestamp":1787299204695,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":95530500,"shares":106095205,"eps":-5.029038,"marketStatus":"盘前交易","change":0,"latestTime":"08-21 04:44:48 EDT","open":84.71,"high":84.74,"low":84.67,"amount":762681290.8075601,"amplitude":0.000827,"askPrice":87,"askSize":1,"bidPrice":84.02,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-5.029038,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787319000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1531886400000,"exchange":"NASDAQ","adjPreClose":84.69,"preHourTrading":{"tag":"盘前","latestPrice":84.69,"preClose":84.69,"latestTime":"04:00 EDT","volume":1,"amount":84.69,"timestamp":1787299204695,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":84.6707,"preClose":84.69,"latestTime":"19:30 EDT","volume":7566,"amount":640762.0507,"timestamp":1787268600702,"change":-0.0193,"changeRate":-0.000228,"amplitude":0.000228},"volumeRatio":3.976936602376454,"impliedVol":0.1242,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/CRNX","defaultTab":"news","newsList":[{"id":"1129072760","title":"Crinetics Pharmaceuticals 宣布：不再提供业绩指引，撤回此前发布的预测","url":"https://stock-news.laohu8.com/highlight/detail?id=1129072760","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129072760?lang=zh_cn&edition=full","pubTime":"2026-08-04 04:25","pubTimestamp":1785788708,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.（股票代码：CRNX）于今日发布重要声明，明确表示将不再提供任何更新的业绩指引。与此同时，该公司还宣布，其此前出台的财务预测与指导方针将被正式撤回。这一决策意味着，市场将无法再依据既有数据来评估其未来表现，投资者需自行调整预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189313061","title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计翻倍增长，机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1189313061","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189313061?lang=zh_cn&edition=full","pubTime":"2026-07-29 00:25","pubTimestamp":1785255911,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.将于2026年08月04日发布财报，市场聚焦新药商业化进展与费用节奏对利润的影响。一致预期显示，本季度公司营收预计为1,484.01万美元，同比增长113.89%；调整后每股收益预计为-1.21美元，同比改善10.07%；息税前利润预计为-1.36亿美元，同比改善20.45%。由于预测未给出毛利率与净利润或净利率的具体值，相关指标不予展示。产品板块在上季度占比达到96.01%，预计本季度营收增长的主要驱动力仍来自产品收入的放量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计翻倍增长，机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116538455","title":"财报前瞻｜Crinetics Pharmaceuticals Inc.机构偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1116538455","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116538455?lang=zh_cn&edition=full","pubTime":"2026-07-28 11:30","pubTimestamp":1785209438,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.将于2026年08月04日美股盘后发布财报，市场聚焦核心管线商业化放量与收购进展对费用和盈利路径的影响。公司收入结构以产品销售为主，上季度“产品”收入为1,030.60万美元，占比96.01%，显示核心商业化产品对现金流与规模化收入的带动作用。发展前景中体量最大的现有业务仍来自核心口服内分泌产品条线，上季度相关产品收入1,030.60万美元，在带动公司整体营收同比+2873.41%中贡献最为明显。从近期覆盖机构的表态看，偏谨慎的观点占优。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百亿美元收购罕见病药企 拓宽内分泌管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651117599?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","BK4588","IE0009355771.USD","PBE","LU2362540622.SGD","IBBQ","LU2362541513.USD","BBH","IE0002270589.USD","LU0566484027.USD","LU0061475181.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU0234570918.USD","VERX","LU2237438978.USD","LU0757428866.USD","LU2417539215.USD","LU0079474960.USD","LU0256863811.USD","SG9999001176.SGD","SG9999013999.USD","LU0432979614.USD","LU1035775433.USD","LU1778281490.HKD","LU2456880835.USD","IE00B894F039.SGD","LU0889565916.HKD","SG9999001176.USD","VRTX","LU1093756168.USD","IDNA","LU1093756325.SGD","BK4007","LU0109394709.USD","IE00BZ9MQY76.HKD","IBB","BK4532","LU2462157665.USD","BIB","IE00B2B36J28.USD","CRNX","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4585","LU1674673428.USD","LU2362541273.HKD","LU1585245621.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161465425","title":"暴涨近99%！Crinetics获福泰制药拟100亿美元现金收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1161465425","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161465425?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:52","pubTimestamp":1783432357,"startTime":"0","endTime":"0","summary":"7月7日，Crinetics美股盘中大幅上涨，涨近99%。消息面上，福泰制药同意以约100亿美元现金收购Crinetics，每股收购价为85美元，较Crinetics周一收盘价溢价约102%。受交易影响，福泰制药股价跌超2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187410524","title":"异动解读｜Crinetics Pharmaceuticals盘中上涨98.85%，福泰制药拟斥资100亿美元溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1187410524","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187410524?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:35","pubTimestamp":1783431342,"startTime":"0","endTime":"0","summary":"7月7日，Crinetics Pharmaceuticals盘中上涨98.85%，报83.5美元/股，成交额28.32亿美元。消息面上，福泰制药宣布将以每股85美元现金收购Crinetics，交易总股权价值约100亿美元，较收购前股价溢价近100%。福泰制药预计此次收购将为其带来约50亿美元峰值销售机会，并于2029年对非GAAP运营收入产生积极贡献。收购消息公布后，Piper Sandler及Cantor Fitzgerald均将Crinetics评级下调至中性，目标价调整至85美元，与收购报价一致。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1156298608","title":"Piper Sandler下调Crinetics评级至中性，目标价降至85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156298608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156298608?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:27","pubTimestamp":1783427261,"startTime":"0","endTime":"0","summary":"投资机构Piper Sandler调整了对Crinetics Pharmaceuticals Inc. (CRNX) 的投资评级，将其从“增持”下调至“中性”。与此同时，该机构也大幅调降了该公司的目标股价，从原先的97美元降至85美元。这一调整反映了分析师对该公司近期前景的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134104489","title":"盘前异动 | 存储股集体回调，美光科技、西部数据跌近5%，中概股多数走低","url":"https://stock-news.laohu8.com/highlight/detail?id=1134104489","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134104489?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:02","pubTimestamp":1783411365,"startTime":"0","endTime":"0","summary":"7月7日，美股三大股指期货盘前表现分化，道指期货升近0.2%，标普500指数期货跌近0.2%，纳指期货跌超0.8%。盘面上，大型科技股小幅上涨，微软涨超0.6%，亚马逊、Meta小幅走高；存储概念股盘前集体下跌，美光科技、西部数据跌近5%，闪迪跌超4%，希捷科技跌超3%；热门中概股多数走低，京东、拼多多跌近1%，百度跌近2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDL","AAPX","AAPB","BABX","NVDU","MSFO","BIDU","NVDY","AMDD","BABA","AMUU","ANV","AMZY","INTC","AMDL","APLY","BABW","MVLL","AMDY","NVII","AMD","KJD","METU","MSFD","MSFL","AMZZ","NVD","PDD","SNDK","MRVU","NVDQ","FBL","KBDU","AMZN","BBYY","AZYY","MULL","NVDG","CRNX","AMDW","FBY","AMDU","MSFX","INTW","NVDX","NVDA","NVDD","WDC","MSFT","PDDL","BABO","NVDS","AMDG","BABU","LINT","SNDG","MSFY","MUD","DAMD","KPDD","MSFW","AAPW","AMZP","NVYY","WDCX","AMZW","AAPY","MU","SNXX","AAPL","SNDC","AAPU","DIPS","KBAB","NVDO","AAPD","BIDG","FBYY","MRVL","07788","AMZD","07388","NTES","MSFU","META","STX","SNDQ","METD","NVDB","NVDW","AMYY","SNDU","METW","JD","AMZU","MUU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRNX","LU0234570918.USD","BK4585","IE0002270589.USD","LU1778281490.HKD","SG9999001176.USD","IE00B2B36J28.USD","LU0079474960.USD","SGXZ57979304.SGD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU2362541273.HKD","LU0823416689.USD","LU0058720904.USD","LU0061475181.USD","LU2324357040.USD","LU2417539215.USD","BIB","IE00B19Z3581.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU2237438978.USD","LU0432979614.USD","BBH","LU0256863811.USD","PBE","LU2362540622.SGD","IBBQ","LU1035775433.USD","BK4533","BK4588","IE00B19Z9Z06.USD","LU1093756325.SGD","LU1674673691.USD","IE00B19Z9P08.USD","LU1585245621.USD","LU0289739699.SGD","SG9999001176.SGD","LU0109394709.USD","VRTX","BK4007","BK4139","IBB","IDNA","LU2456880835.USD","LU1093756168.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188431917","title":"美股夜盘｜存储概念股普跌，美光科技、闪迪跌超2%；Crinetics涨超100%、费哲金融服务涨6%、Rivian跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188431917","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188431917?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:06","pubTimestamp":1783382813,"startTime":"0","endTime":"0","summary":"费哲金融服务涨6.2%，《华尔街日报》称多家大型银行探讨收购其旗下支付网络，或为绕开借记卡手续费上限。SpaceX跌1.75%，社交媒体讨论称其股票面临破发压力。Rivian Automotive, Inc.  跌8.99%，宣布增发7500万股以履行美国能源部贷款相关出资，并公布二季度营收预期，且拟授予承销商30天超额配售权，稀释担忧压制股价。存储芯片股下跌，Roundhill Memory ETF跌2.75%，闪迪跌2.55%，美光科技跌2.31%，西部数据跌1.93%，希捷科技跌1.18%。其中，美光科技受高管减持消息影响。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","LU0082616367.USD","MULL","TMSL","BK4575","BK4596","BK4533","LU1861220033.SGD","LU0054578231.USD","LU1046421795.USD","OPTZ","IE0009356076.USD","IE00B1XK9C88.USD","LU1316542783.SGD","LU1803068979.SGD","EMSF","LU0127658192.USD","LU2168564149.EUR","IE00BK4W5L77.USD","FSMD","LU1868837136.USD","LU0203347892.USD","AIQ","LU0792757196.USD","LU0157215616.USD","LU0274383776.USD","FCUS","SG9999001424.SGD","LU2471134952.CNY","LU0859254822.USD","IE00B7SZLL34.SGD","IETC","LU0203345920.USD","RVNL","LU0354030438.USD","XLK","LU2048586759.USD","XNTK","PTF","LU1914381329.SGD","BK4512","IE00BKDWB100.SGD","LU0963586101.USD","IE00BK4W5M84.HKD","BK4547","LEGR","LU0096364046.USD","VGT","SCHM","LU2168564222.USD","LU1366333091.USD","LU0061475181.USD","BK4579","LU2102340556.USD","LU0154236417.USD","FISV","SNDK","DRAM","BK4585","LU0081259029.USD","IXN","BK4227","SOXQ","LU0980610538.SGD","FDRV","AIS","LU0354030511.USD","FXL","LU0683600562.USD","CHPS","SNDG","LU2089985449.USD","LU0070302665.USD","LU2471134796.USD","EGGY","LU2458330169.SGD","LU0889566641.SGD","AIFD","FINX","LU1201861249.SGD","IE0002270589.USD","BK4527","LU2290526834.HKD","LU2458330243.SGD","IE000M9KFDE8.USD","BAI","LU0648001328.SGD","LU0208291251.USD","SNDC","SNDQ","IE00B19Z3B42.SGD","LU1852331112.SGD","LU0320765489.SGD","CRNX","CNAV","LU0238689110.USD","RAM","FTEC","SNDU","USXF","LU2357627491.SGD","LU2250418816.HKD","BK4141","FTXL","EFIV","LU2054465674.USD","LU1868836757.USD","LU2125909759.SGD","LU2360107168.USD","LU0109392836.USD","BK4170","LU2543165471.USD","LU0642271901.SGD","WUGI","IE00B5949003.HKD","SMH","TRFK","CGGO","LU1823568750.SGD","COWG","LU2750360997.AUD","LU0889565833.HKD","LU2168563687.JPY","LU2471134879.HKD","FAI","WLDR","LU2471134523.USD","JGRO","IDRV","BK4106","LU1923622291.USD","BK4566","BK4554","LU2931357623.SGD","IE00B19Z3581.USD","LU1989764748.USD","BK4532","LU1989764664.SGD","LU2211815571.USD","GB00BDT5M118.USD","LU1201861165.SGD","SOXX","SNXX","LU0648000940.SGD","LU1267930813.SGD","MUD","LU2168564495.EUR","DRAL","LU0130103400.USD","LU1323610961.USD","LU1861217088.USD","LU2168564065.EUR","MU","PSI","LU0719512351.SGD","IE00BJLML261.HKD","FDTX","CHAT","SHOC","BK4605","LU1861215975.USD","ARTY","LU0787776722.HKD","LU2750360641.GBP","RULE","BK4555","BK4099","MUU","IE00BWXC8680.SGD","LU0130102774.USD","LU2286300806.USD","LU2125909916.SGD","LU1868836591.USD","BK4553","BK4588","LU0056508442.USD","QQQG","LU1861220207.SGD","SCHA","LU2360106780.USD","LU1868836914.USD","RIVN","LU1868837300.USD","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1198601451","title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1198601451","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198601451?lang=zh_cn&edition=full","pubTime":"2026-07-07 06:13","pubTimestamp":1783376037,"startTime":"0","endTime":"0","summary":"7月7日，Vertex制药公司周一宣布，将以每股$85.00的现金价格收购Crinetics制药公司，交易总股权价值约为100亿美元，扣除预计所获现金后净值约为88亿美元。消息公布后，Crinetics盘后股价飙升近100%。两家公司董事会均已一致批准此次交易。交易预计于2026年第三季度完成，尚需满足惯常交割条件，包括获得监管机构批准及Crinetics股东批准。Crinetics旗下产品PALSONIFY已于2025年9月获得美国食品药品监督管理局批准，近期亦获欧洲药品管理局批准上市。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","SG9999001176.USD","LU1585245621.USD","BK4532","LU2237438978.USD","SG9999013999.USD","IBBQ","LU0058720904.USD","LU1093756168.USD","LU2462157665.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2417539215.USD","LU0256863811.USD","CRNX","LU0289739699.SGD","PBE","IE0002141913.USD","SG9999001176.SGD","IE0002270589.USD","IE00B4R5TH58.HKD","LU0061475181.USD","BBH","BK4007","IE00BZ9MQY76.HKD","LU1674673428.USD","LU2236285917.USD","LU2362540622.SGD","LU2362541273.HKD","IBB","LU1674673691.USD","LU0109394709.USD","BK4585","VRTX","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","BIB","LU0432979614.USD","LU1035775433.USD","LU2324357040.USD","IE00B19Z9Z06.USD","LU0234570918.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU1093756325.SGD","LU2362541513.USD","LU0079474960.USD","LU1778281490.HKD","LU2456880835.USD","LU1430594728.SGD","IDNA","LU0417517546.SGD","BK4533","BK4567","LU0823416689.USD","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","BK4007","LU2417539215.USD","SG9999013999.USD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","BBH","LU0061475181.USD","LU1035775433.USD","CRNX","IE00B19Z9Z06.USD","LU0432979614.USD","LU1093756168.USD","SG9999001176.SGD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","LU1430594728.SGD","VRTX","LU2362540622.SGD","LU0079474960.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0417517546.SGD","SGXZ57979304.SGD","IBBQ","LU1674673691.USD","LU2237438978.USD","LU1585245621.USD","LU2362541273.HKD","LU2236285917.USD","LU0823416689.USD","LU1069344957.HKD","LU0320765992.SGD","LU0289739699.SGD","IE00B19Z9P08.USD","SG9999001176.USD","LU2462157665.USD","IE00B4R5TH58.HKD","LU1674673428.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","BK4139","IE0002270589.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","IDNA","IE00B19Z3B42.SGD","IE0009355771.USD","BK4532","LU2456880835.USD","IBB","BK4585","PBE","LU0109394709.USD","BIB","BK4588","IE00B19Z3581.USD","LU0234570918.USD","LU2324357040.USD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU0432979614.USD","LU1778281490.HKD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IBB","BK4007","LU0823416689.USD","LU1585245621.USD","LU2362541273.HKD","SG9999013999.USD","IE0002141913.USD","LU1430594728.SGD","LU2324357040.USD","LU0289739699.SGD","BK4533","LU0234570918.USD","LU0320765992.SGD","VRTX","LU2362541513.USD","LU1674673428.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU2456880835.USD","LU2362540622.SGD","CRNX","BK4588","SGXZ57979304.SGD","LU0061475181.USD","LU0058720904.USD","LU2417539215.USD","BIB","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0079474960.USD","PBE","IE00B19Z9P08.USD","BK4139","SG9999001176.USD","IE0009355771.USD","LU0109394709.USD","IBBQ","LU1093756325.SGD","BK4567","BK4532","IE00B4R5TH58.HKD","LU1069344957.HKD","LU0417517546.SGD","LU1093756168.USD","LU1674673691.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","IE0002270589.USD","BK4585","IDNA","LU0889565916.HKD","LU2462157665.USD","LU2237438978.USD","SG9999001176.SGD","BBH","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117418128","title":"Crinetics公布Atumelnant治疗先天性肾上腺皮质增生症二期试验完整结果，并于Endo 2026进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1117418128","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117418128?lang=zh_cn&edition=full","pubTime":"2026-06-15 04:30","pubTimestamp":1781469015,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 在Endo 2026会议上，以口头报告形式公布了其药物Atumelnant用于治疗先天性肾上腺皮质增生症的二期临床试验完整数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101516072","title":"Crinetics Pharmaceuticals Inc. 预期2026年GAAP运营支出6-6.5亿美元；非GAAP运营支出4.8-5.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101516072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101516072?lang=zh_cn&edition=full","pubTime":"2026-05-08 04:29","pubTimestamp":1778185754,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 公布了其2026财年的财务指引。该公司预计，按照美国通用会计准则（GAAP）计算，其2026年的运营支出将在6亿美元至6.5亿美元之间。同时，根据非美国通用会计准则（Non-GAAP）测算，公司预期的运营支出范围则为4.8亿美元至5.2亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517589074","title":"Crinetics Pharmaceuticals, Inc.2024财年实现净利润-2.98亿美元，同比减少38.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517589074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517589074?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363257,"startTime":"0","endTime":"0","summary":"3月8日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-2.98亿美元，同比减少38.60%；其中营业收入为1.04百万美元，同比减少74.06%，每股基本收益为-3.69美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债4.01亿美元，其中短期债务7.15百万美元，资产负债比为4.31，流动比率为0.24。机构评级：截至2025年3月8日，当前有14家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为75.64美元，其中最低目标价为55.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514904376","title":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904376","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514904376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171905954","title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1171905954","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171905954?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:22","pubTimestamp":1740756147,"startTime":"0","endTime":"0","summary":"Crinetics制药公司今日盘中大涨5.09%,引发了市场的广泛关注。\n公司日前公布的最新季度业绩显示,2024年第四季度,公司调整后每股亏损为88美分,同比收窄2美分,略好于分析师预期的89美分亏损。尽管如此,公司当季实际亏损8060万美元,同比加大。\n不过,公司当季度业绩整体表现略好于预期,以及分析师看好其长期前景,推动了公司股价今日盘中出现较大涨幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125291574","title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1125291574","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125291574?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:24","pubTimestamp":1740691484,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals  公布季度每股亏损 $，与分析师一致预期相符。这比去年同期每股亏损 $ 增加了 2.22%。以上内容来自Benzinga Earnings专栏，原文如下：Crinetics Pharmaceuticals  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 2.22 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crinetics.com;ir.crinetics.com;investors.vrtx.com","stockEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":0.0094},{"period":"3month","weight":1.3014},{"period":"6month","weight":0.9496},{"period":"1year","weight":1.9113},{"period":"ytd","weight":0.8193}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.078473},{"month":2,"riseRate":0.5,"avgChangeRate":-0.021565},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056934},{"month":4,"riseRate":0.625,"avgChangeRate":0.06869},{"month":5,"riseRate":0.5,"avgChangeRate":-0.026047},{"month":6,"riseRate":0.625,"avgChangeRate":0.005036},{"month":7,"riseRate":0.5,"avgChangeRate":0.131715},{"month":8,"riseRate":0.555556,"avgChangeRate":0.050854},{"month":9,"riseRate":0.375,"avgChangeRate":0.104829},{"month":10,"riseRate":0.5,"avgChangeRate":0.007484},{"month":11,"riseRate":0.875,"avgChangeRate":0.104868},{"month":12,"riseRate":0.75,"avgChangeRate":0.036899}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}